Novel Compounds as TIPARP Inhibitors for Treating Head and Neck Squamous Cell Carcinoma (HNSCC)

Provided herein are novel compounds as TIPARP inhibitors, pharmaceutical compositions, use of such compounds in treating head and neck squamous cell carcinoma (HNSCC), and processes for preparing such compounds.

Authors

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2026-01-07
DOI
https://doi.org/10.1021/acsmedchemlett.6c00001
Primary Topic
Protein Kinase Regulation and GTPase Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Compounds as TIPARP Inhibitors for Treating Head and Neck Squamous Cell Carcinoma (HNSCC)

R. W. Sabnis
ACS Medicinal Chemistry Letters
Protein Kinase Regulation and GTPase Signaling
article

Novel Compounds as TIPARP Inhibitors for Treating Head and Neck Squamous Cell Carcinoma (HNSCC)

R. W. Sabnis
article en

Abstract

Provided herein are novel compounds as TIPARP inhibitors, pharmaceutical compositions, use of such compounds in treating head and neck squamous cell carcinoma (HNSCC), and processes for preparing such compounds.

ACS Medicinal Chemistry LettersVol. 17(2)
Zero hunger
Openalex Percentile: Top 95%
Protein Kinase Regulation and GTPase Signaling
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel Compounds as TIPARP Inhibitors for Treating Head and Neck Squamous Cell Carcinoma (HNSCC) — R. W. Sabnis · ACS Medicinal Chemistry Letters (2026) | TGRS Research Map | TGRS